期刊文献+

通过眼科院内会诊情况看综合医院的发展趋势

Viewing the Developing Trends of One General Hospital from the Ophthalmology Consultation
下载PDF
导出
摘要 眼科学与其他临床学科有着密切的关系,许多全身疾病在眼部有特定的表现和并发证。通过对综合性医院分析发现,从医院临床科室患者眼科会诊情况可以分析和反映出医院的发展趋势。 Ophthalmology is connected closely with other clinical fields, and many systemic diseases have special ophthalmology symptoms and complications. We analyzed and concluded that, the developing treads of our hospital can be viewed from the ophthalmology consultation.
作者 王静波
机构地区 解放军第
出处 《中国社会医学杂志》 2012年第6期393-394,共2页 Chinese Journal of Social Medicine
基金 国家自然科学基金项目(81100684)
关键词 眼科学 会诊 综合医院 发展趋势 Ophthalmology Consultation General hospital Developing trends
  • 相关文献

参考文献5

二级参考文献19

  • 1Evoli A, Bianchi MR, Riso R, et al. Response to therapy in myasthenia gravis with anti MuSK antibodies[J]. Ann NY Acad Sci, 2008, 1132:76 -83.
  • 2Guptill JT, Sander DB. Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis[J]. Curr Opin Neuro, 2010, 23: 530-535.
  • 3Skeie GO, Apostolski S, Evoli A. Guidelines for treatment of autoimmune neuromuscular transmission disorders[J]. Eur J Neurol, 2010, 17:893 -902.
  • 4Gajdos P, Chevret S, Toyka K. Intravenous immunoglobutin for myasthenia gravis [J]. Cochrane Database Syst Rev, 2008: CD002277.
  • 5Yeh JH, Chiu HC. Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatmet of patients with myasthenia gravis[J]. J Neurol, 2000, 247(7): 510-513.
  • 6Hehir MK, Burns TM, Alpers J, et al. Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis:outcomes in 102 patients[J]. Muscle Nerve, 2010, 41(5): 593-598.
  • 7Hart IK, Sathasivam S, Sharshar T. Immunosuppressive agents for myasthenia gravis[J]. Cochrane Database Syst Rev, 2007, (4) : CD005224.
  • 8Drachman DB, Brodsky RA. High-dose therapy for autoimmune neurologie diseases[J].Curr Opin Oncol, 2005, 17: 83-88.
  • 9Burusnukul P, Brennan TD, Cupler EJ. Prolonged improvement after rituximab: two cases of resistant muscle-specific receptor tyrosine kinase + myasthenia gravis[J]. J Clin Neuromuscul Dis, 2010, 12(2) : 85 -87.
  • 10Yu J, Zheng C, Ren X, et al. Intravenous administration of bone marrow mesenehymal stem cells benefits experimental autoimmune myasthenia gravis mice through an immunomodulatory action[J].Scand J Immunol, 2010, 72(3): 242- 249.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部